Terns Pharmaceuticals, Inc. (TERN)

NASDAQ

$--

(--)

After-Hours

Terns Pharmaceuticals, Inc. (TERN) Live Price Chart

Last updated: ⁦2026-10-01 20:33:40⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Terns Pharmaceuticals, Inc. (TERN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Terns Pharmaceuticals, Inc. (TERN) After-Hours Stock Price

Terns Pharmaceuticals, Inc. (TERN) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.

After-hours trading shows how investors are pricing TERN after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.

Terns Pharmaceuticals, Inc. (TERN) 7-Day Stock Price Change

Over the past seven days, Terns Pharmaceuticals, Inc. (TERN) moved from $52,88 to $52,95, representing a gain of 0,14% ($0,08).

The stock traded between $52,86 and $52,98 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 3,50 million shares, down versus the previous seven-day period, indicating lower trading activity.

What is Terns Pharmaceuticals, Inc. (TERN)?

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of chronic disease. The company's oncology asset is TERN-701, a novel, oral allosteric BCR-ABL1 inhibitor for CML currently in Phase 1/2 development. The company's legacy metabolic programs include TERN-501, a clinical-stage thyroid hormone receptor-Beta for MASH and/or obesity, and TERN-801, a glucose-dependent insulinotropic polypeptide receptor antagonist development candidate for obesity. The company is seeking strategic partners to advance the TERN-501 and TERN-801 programs.

Terns Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	59
Exchange	NASDAQ
Company Website	https://www.ternspharma.com

How to Buy Terns Pharmaceuticals, Inc. (TERN) Stock on MEXC

Eligible investors can buy real shares of Terns Pharmaceuticals, Inc. (TERN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TERN and Place Your Order

Open the RealStocks trading page and search for TERN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Terns Pharmaceuticals, Inc. (TERN) stock price today?

Terns Pharmaceuticals, Inc. (TERN) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is TERN stock going up or down today?

As of --, TERN is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is TERN pre-market price?

As of --, TERN is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TERN after-hours price?

As of --, TERN is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TERN stock trading now?

TERN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TERN sit relative to its 52-week high and low?

Over the past 52 weeks, TERN has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Terns Pharmaceuticals, Inc. in?

Terns Pharmaceuticals, Inc. (TERN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Terns Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Terns Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TERN valued in terms of P/E ratio and EPS?

TERN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Terns Pharmaceuticals, Inc. pay a dividend?

Terns Pharmaceuticals, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.